Heczey A - Search Results

1

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.

Heczey A, Louis CU, Savoldo B, Dakhova O, Durett A, Grilley B, Liu H, Wu MF, Mei Z, Gee A, Mehta B, Zhang H, Mahmood N, Tashiro H, Heslop HE, Dotti G, Rooney CM, Brenner MK. Heczey A, et al. Mol Ther. 2017 Sep 6;25(9):2214-2224. doi: 10.1016/j.ymthe.2017.05.012. Epub 2017 Jun 9. Mol Ther. 2017. PMID: 28602436 Free PMC article.

2

Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020.

Arnett A, Siegel DA, Dai S, Thompson TD, Foster J, di Pierro EJ, Momin B, Lupo PJ, Heczey A. Arnett A, et al. Among authors: heczey a. medRxiv [Preprint]. 2024 Apr 5:2024.03.25.24304564. doi: 10.1101/2024.03.25.24304564. medRxiv. 2024. Update in: Cancer Epidemiol. 2024 Oct;92:102610. doi: 10.1016/j.canep.2024.102610 PMID: 38633779 Free PMC article. Updated. Preprint.

3

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.

Liu D, Song L, Wei J, Courtney AN, Gao X, Marinova E, Guo L, Heczey A, Asgharzadeh S, Kim E, Dotti G, Metelitsa LS. Liu D, et al. Among authors: heczey a. J Clin Invest. 2012 Jun;122(6):2221-33. doi: 10.1172/JCI59535. Epub 2012 May 8. J Clin Invest. 2012. PMID: 22565311 Free PMC article. Clinical Trial.

4

Advances in chimeric antigen receptor immunotherapy for neuroblastoma.

Heczey A, Louis CU. Heczey A, et al. Discov Med. 2013 Dec;16(90):287-94. Discov Med. 2013. PMID: 24333408 Free PMC article. Review.

5

Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.

Heczey A, Liu D, Tian G, Courtney AN, Wei J, Marinova E, Gao X, Guo L, Yvon E, Hicks J, Liu H, Dotti G, Metelitsa LS. Heczey A, et al. Blood. 2014 Oct 30;124(18):2824-33. doi: 10.1182/blood-2013-11-541235. Epub 2014 Jul 21. Blood. 2014. PMID: 25049283 Free PMC article.

6

IMAGES IN CLINICAL MEDICINE. Osteopetrosis and Erlenmeyer-Flask Deformity.

Heczey A, Louis C. Heczey A, et al. N Engl J Med. 2015 Sep 3;373(10):e12. doi: 10.1056/NEJMicm1407743. N Engl J Med. 2015. PMID: 26332566 Free PMC article. No abstract available.

7

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo.

Tian G, Courtney AN, Jena B, Heczey A, Liu D, Marinova E, Guo L, Xu X, Torikai H, Mo Q, Dotti G, Cooper LJ, Metelitsa LS. Tian G, et al. Among authors: heczey a. J Clin Invest. 2016 Jun 1;126(6):2341-55. doi: 10.1172/JCI83476. Epub 2016 May 16. J Clin Invest. 2016. PMID: 27183388 Free PMC article.

8

Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.

Li W, Guo L, Rathi P, Marinova E, Gao X, Wu MF, Liu H, Dotti G, Gottschalk S, Metelitsa LS, Heczey A. Li W, et al. Among authors: heczey a. Hum Gene Ther. 2017 May;28(5):437-448. doi: 10.1089/hum.2016.025. Epub 2016 Aug 16. Hum Gene Ther. 2017. PMID: 27530312 Free PMC article.

9

T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.

Szoor A, Vaidya A, Velasquez MP, Mei Z, Galvan DL, Torres D, Gee A, Heczey A, Gottschalk S. Szoor A, et al. Among authors: heczey a. Mol Ther Oncolytics. 2017 Jul 28;6:69-79. doi: 10.1016/j.omto.2017.07.002. eCollection 2017 Sep 15. Mol Ther Oncolytics. 2017. PMID: 28856237 Free PMC article.

10

Alliance of the Titans: An Effective Combination of a TKI with CAR T Cells.

Heczey A. Heczey A. Mol Ther. 2019 Aug 7;27(8):1348-1349. doi: 10.1016/j.ymthe.2019.07.008. Epub 2019 Jul 20. Mol Ther. 2019. PMID: 31337604 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters